Published in Clin Microbiol Rev on July 01, 1999
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A (2000) 2.83
Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol (2012) 2.02
Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol (2008) 1.94
Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci U S A (2006) 1.71
The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia (2009) 1.49
The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J Virol (2002) 1.45
Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. Virology (2009) 1.18
Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors. BMC Immunol (2005) 0.97
Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus. BMC Microbiol (2002) 0.91
The roles of viruses in brain tumor initiation and oncomodulation. J Neurooncol (2011) 0.88
Identification of novel viral interleukin-10 isoforms of human cytomegalovirus AD169. Virus Res (2007) 0.86
Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis. Infect Disord Drug Targets (2011) 0.85
Analysis of colorectal cancers for human cytomegalovirus presence. Infect Agent Cancer (2009) 0.84
Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1. Clin Oral Investig (2011) 0.84
Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection. J Virol (2006) 0.82
The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes viruses. Med Hypotheses (2013) 0.80
Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas. J Clin Pathol (2004) 0.78
Cytomegalovirus occurrence in chronic periodontitis and in carcinoma of the cervix: an exploratory study. J Clin Diagn Res (2012) 0.77
Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection. J Virol (2016) 0.76
β-HHVs and HHV-8 in Lymphoproliferative Disorders. Mediterr J Hematol Infect Dis (2011) 0.76
Basic local alignment search tool. J Mol Biol (1990) 659.07
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
p53 mutations in human cancers. Science (1991) 31.96
The retinoblastoma protein and cell cycle control. Cell (1995) 20.21
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell (1992) 19.87
A workbench for multiple alignment construction and analysis. Proteins (1991) 16.96
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol (1990) 16.31
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell (1995) 14.90
p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (1993) 13.46
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A (1996) 12.89
Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (1990) 12.88
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98
E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (1992) 10.28
Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell (1982) 9.27
Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A (1992) 8.87
Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet (1988) 8.76
PROSITE: a dictionary of sites and patterns in proteins. Nucleic Acids Res (1992) 8.52
Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science (1986) 8.15
EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (1970) 8.08
mdm2 expression is induced by wild type p53 activity. EMBO J (1993) 8.01
Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature (1990) 7.11
Structural analysis of the major immediate early gene of human cytomegalovirus. J Virol (1984) 6.67
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol (1997) 6.61
Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science (1994) 6.11
Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol (1981) 6.02
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
Lipoproteins in bacteria. J Bioenerg Biomembr (1990) 5.96
Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev (1994) 5.68
Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. J Virol (1985) 5.09
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol (1996) 5.05
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94
Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature (1984) 4.86
Binding of general transcription factor TFIIB to an acidic activating region. Nature (1991) 4.71
trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus. J Virol (1988) 4.69
Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell (1991) 4.66
Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature (1991) 4.62
Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J Virol (1989) 4.25
Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J Virol (1990) 4.24
Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol (1995) 4.22
Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci U S A (1992) 4.06
Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins. J Virol (1990) 4.01
Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J Virol (1989) 3.98
Structural aspects of the p53 protein in relation to gene evolution. Oncogene (1990) 3.64
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med (1996) 3.61
The PROSITE dictionary of sites and patterns in proteins, its current status. Nucleic Acids Res (1993) 3.60
Inhibition of DNA replication factor RPA by p53. Nature (1993) 3.58
Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci U S A (1991) 3.45
Widespread presence of histologically occult cytomegalovirus. Hum Pathol (1984) 3.45
Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology (1973) 3.43
A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med (1992) 3.42
Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA (1986) 3.37
Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol (1995) 3.18
p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol (1985) 3.13
The tumor suppressor genes. Annu Rev Biochem (1993) 3.12
Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis (1981) 2.96
Direct interaction between adenovirus E1A protein and the TATA box binding transcription factor IID. Proc Natl Acad Sci U S A (1991) 2.95
Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J Virol (1992) 2.95
In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med (1988) 2.81
The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J (1990) 2.80
A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2. J Virol (1991) 2.80
The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site. J Virol (1990) 2.77
p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes Dev (1993) 2.74
Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site. J Virol (1991) 2.61
An immediate early gene of human cytomegalovirus encodes a potential membrane glycoprotein. Virology (1988) 2.59
HBLV (or HHV-6) in human cell lines. Nature (1987) 2.53
Sequence of the short unique region, short repeats, and part of the long repeats of human cytomegalovirus. J Mol Biol (1986) 2.50
Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis (1992) 2.42
The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol Cell Biol (1993) 2.37
Human herpesvirus 6 is closely related to human cytomegalovirus. J Virol (1990) 2.34
Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A (1995) 2.33
Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol (1989) 2.28
Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter. J Virol (1990) 2.28
Breast milk and the risk of cytomegalovirus infection. N Engl J Med (1980) 2.27
Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J (1990) 2.26
Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis (1991) 2.25
Herpesvirus infections in the acquired immune deficiency syndrome. JAMA (1984) 2.25
Genomic analysis of the human B-lymphotropic virus (HBLV). Science (1986) 2.23
Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol (1989) 2.18
An in vitro system for human cytomegalovirus immediate early 2 protein (IE2)-mediated site-dependent repression of transcription and direct binding of IE2 to the major immediate early promoter. Proc Natl Acad Sci U S A (1993) 2.13
Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell (1994) 2.06
Demonstration of cytomegalovirus in semen. N Engl J Med (1972) 2.01
Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature (1989) 1.96
Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J Virol (1994) 1.94
Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer (1980) 1.90
Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J (1989) 1.88
Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate "hit-and-run" oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci U S A (1997) 1.85
Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet (1991) 1.84
Inhibition of viral and cellular promoters by human wild-type p53. J Virol (1992) 1.83
High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol (1990) 1.78
Oncogenic transformation of human embryo lung cells by human cytomegalovirus. Science (1976) 1.76
RB kinases and RB-binding proteins: new points of view. Trends Biochem Sci (1997) 1.73
Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6. Nature (1991) 1.73
The retinoblastoma tumor suppressor protein. Adv Cancer Res (1994) 1.72
Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus. J Virol (1993) 1.68
p53 domains: structure, oligomerization, and transformation. Mol Cell Biol (1994) 1.68
Changing trends in sexually transmitted infections at a Regional STD Centre in north India. Indian J Med Res (2006) 2.72
Cutaneous tuberculosis: a twenty-year prospective study. Int J Tuberc Lung Dis (1999) 2.07
Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol (1998) 2.02
Amino-acid acceptor activity of the "70S-associated" 4S RNA from avian myeloblastosis virus. Proc Natl Acad Sci U S A (1973) 1.78
Childhood cutaneous tuberculosis: a study over 25 years from northern India. Int J Dermatol (2001) 1.73
Thermally induced intracellular alteration of ribosomal ribonucleic acid. J Bacteriol (1970) 1.64
Base composition differences between avian myeloblastosis virus transfer RNA and transfer RNA isolated from host cells. Proc Natl Acad Sci U S A (1971) 1.63
Prevalence of RTI/STI agents and HIV infection in symptomatic and asymptomatic women attending peripheral health set-ups in Delhi, India. Epidemiol Infect (2007) 1.60
Ophiasis inversus: a rare pattern of alopecia areata. Pediatr Dermatol (1998) 1.54
Isolation and characterization of poly(A)-containing polyoma "early" and "late" messenger RNAs. Nucleic Acids Res (1976) 1.48
Value of different cut-off points of tuberculin skin test to diagnose tuberculosis among patients with respiratory symptoms in a chest clinic. J Assoc Physicians India (2001) 1.46
Human cytomegalovirus completely helps adeno-associated virus replication. Virology (1985) 1.39
Neoplastic transformation by a cloned human cytomegalovirus DNA fragment uniquely homologous to one of the transforming regions of herpes simplex virus type 2. Proc Natl Acad Sci U S A (1983) 1.29
Minor base composition of "70S-associated" 4S RNA from avian myeloblastosis virus. Proc Natl Acad Sci U S A (1973) 1.26
The control of SV40 transcription during a lytic infection: late RNA synthesis in the presence of inhibitors of DNA replication. Nucleic Acids Res (1977) 1.24
Ribosome synthesis in thermally shocked cells of Staphylococcus aureus. J Bacteriol (1972) 1.20
Discrepant estrogen receptor protein levels according to surgical technique. Am J Surg (1979) 1.18
DNA modifying enzymes of Agrobacterium tumefaciens: effect of DNA topoisomerase, restriction endonuclease, and unique DNA endonuclease on plasmid and plant DNA. Proc Natl Acad Sci U S A (1978) 1.15
Malignant syphilis: a review. AIDS Patient Care STDS (1998) 1.07
Localization and DNA sequence analysis of the transforming domain (mtrII) of human cytomegalovirus. Proc Natl Acad Sci U S A (1988) 1.07
Isolation and characterization of poly(A)-containing intranuclear polyoma-specific "giant" RNA'S. Nucleic Acids Res (1976) 1.07
Human cytomegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription. J Virol (1996) 1.03
Multiple transforming regions of human cytomegalovirus DNA. J Virol (1986) 1.03
Mucocutaneous manifestations of secondary syphilis in north Indian patients: a changing scenario? J Dermatol (2001) 1.01
A transforming fragment within the direct repeat region of human herpesvirus type 6 that transactivates HIV-1. Oncogene (1994) 1.00
Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53. Oncogene (1997) 0.99
Isolation of human cytomegalovirus DNA from infected cells. Intervirology (1983) 0.98
Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12). J Clin Virol (2000) 0.98
Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6. Virology (1994) 0.96
Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters. J Virol (1995) 0.92
Localization and sequence analysis of morphological transforming region III within human cytomegalovirus strain Towne. Intervirology (1993) 0.92
Analysis of human KS biopsies and cloned cell lines for cytomegalovirus, HIV-1, and other selected DNA virus sequences. AIDS Res Hum Retroviruses (1989) 0.91
Defective virions of human cytomegalovirus. Virology (1979) 0.90
Nonoperative management of distal fingertip amputations in children. Pediatrics (1979) 0.89
Cytomegalovirus replication in primary and passaged human placental cells. Intervirology (1981) 0.89
Comparison of microtiter procedures with the plaque technique for assay of vesicular stomatitis virus. Appl Microbiol (1971) 0.88
Curcumin as a promising anticandidal of clinical interest. Can J Microbiol (2011) 0.85
Prevalence of intestinal parasitic infections in HIV-infected individuals and their relationship with immune status. Indian J Med Microbiol (2013) 0.85
Tumor progression mediated by two cooperating DNA segments of human cytomegalovirus. J Virol (1989) 0.84
Characterization and location of myc homologous sequences in human cytomegalovirus DNA. Proc Natl Acad Sci U S A (1983) 0.82
A 79 amino acid oncogene is responsible for human cytomegalovirus mtrII induced malignant transformation. Arch Virol (1994) 0.82
Effect of 5-azacytidine on cytoplasmic ribosomal and messenger ribonucleic acids in BSC-1 cells. Antimicrob Agents Chemother (1979) 0.81
Identification of two promoters within human cytomegalovirus morphologic transforming region II. Intervirology (1992) 0.80
Breast abscess: management in subareolar and peripheral disease. N Y State J Med (1981) 0.80
Nail changes in 1000 Indian patients with alopecia areata. J Eur Acad Dermatol Venereol (1998) 0.79
Secretion of RNA by normal and transformed cells. Exp Cell Res (1972) 0.79
Inhibition of SV40 replication by 5-azacytidine: effect on DNA synthesis and conformation. Virology (1979) 0.79
Reappraisal of Ikeda's classification of alopecia areata: analysis of 356 cases from Chandigarh, India. J Dermatol (1998) 0.79
Effect of azacytidine in SV40-infected BSC-1 cells. Intervirology (1979) 0.79
The human cytomegalovirus mtrII colinear region in strain Tanaka is transformation defective. J Virol (1989) 0.79
Replication of herpesviruses and latency. Can J Microbiol (1979) 0.77
Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation. Oncogene (1997) 0.77
Differences in retention and expression of transfected human cytomegalovirus Towne XbaI-E transforming fragment in human cervical and NIH 3T3 lines. Intervirology (1992) 0.77
Treatment of widespread alopecia areata in young patients with monthly oral corticosteroid pulse. Pediatr Dermatol (1998) 0.76
Effect of azacytidine on Simian Virus 40 nucleoprotein complexes. Antimicrob Agents Chemother (1979) 0.75
Genital ulcer and viral warts. Indian J Dermatol Venereol Leprol (2010) 0.75
Analysis of peripheral blood lymphocytes of AIDS and high-risk patients for human cytomegalovirus transforming DNA sequences. Intervirology (1991) 0.75
Mupirocin in folliculitis cruris pustulosa et atrophicans. Indian J Dermatol Venereol Leprol (2010) 0.75
Absence of DNA-associated RNA in the fully repressed nucleus of chicken erythrocyte. Exp Cell Res (1974) 0.75
Minor base changes in transfer ribonucleic acid in avian myeloblastosis virus. Bibl Haematol (1973) 0.75
Evaluation of test results of microbiology laboratories of North India for standard tests for syphilis under an external quality assurance scheme. Eur J Clin Microbiol Infect Dis (2008) 0.75
Topical immunotherapy with diphencyprone in Indians with alopecia areata. Clin Exp Dermatol (1998) 0.75
Malignant syphilis: an immunological puzzle. Int J STD AIDS (1998) 0.75
Isolation and partial characterization of nucleocapsid forms from cells infected with human cytomegalovirus strains AD169 and Towne. Intervirology (1988) 0.75